A Study of Multiple Doses of Lasmiditan in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

January 2, 2018

Study Completion Date

January 2, 2018

Conditions

Healthy

Interventions

DRUG

Probe Drug Cocktail

Administered orally

DRUG

Lasmiditan

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

Covance Daytona Beach, Daytona Beach

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03252015 - A Study of Multiple Doses of Lasmiditan in Healthy Participants | Biotech Hunter | Biotech Hunter